Advertisement

Intron-Mediated RNA Interference and microRNA Biogenesis

Protocol
First Online:
Part of the Methods in Molecular Biology book series (MIMB, volume 487)

Abstract

Nearly 97% of the human genome is non-coding DNA, and introns occupy most of it around the gene-coding regions. Numerous intronic sequences have been recently found to encode microRNAs, which are responsible for RNA-mediated gene silencing through RNA interference (RNAi)-like pathways. microRNAs (miRNAs), small single-stranded regulatory RNAs capable of interfering with intracellular messenger RNAs (mRNAs) that contain either complete or partial complementarity, are useful for the design of new therapies against cancer polymorphism and viral mutation. This flexible characteristic is different from double-stranded siRNAs (small interfering RNAs) because a much more rigid complementarity is required for siRNA-induced RNAi gene silencing. miRNAs were firstly discovered in Caenorhabditis elegans as native RNA fragments that modulate a wide range of genetic regulatory pathways during embryonic development. Currently, varieties of miRNAs are widely reported in plants, animals and even microbes. Intronic microRNA is a new class of miRNAs derived from the processing of gene introns. The intronic miRNAs differ uniquely from previously described intergenic miRNAs in the requirement of type II RNA polymerases (Pol-II) and spliceosomal components for their biogenesis. Several kinds of intronic miRNAs have been identified in C. elegans, mouse and human cells; however, neither function nor application has been reported. Here, we show for the first time that intron-derived miRNAs are able to induce RNA interference in not only human and mouse cells but also zebrafishes, chicken embryos and adult mice, demonstrating the evolutionary preservation of the intron-mediated gene silencing through miRNA functionality in cell and in vivo. These findings suggest an intracellular miRNA-mediated gene regulatory system, fine-tuning the degradation of protein-coding messenger RNAs.

Key Words:

RNA interference intronic microRNA microRNA RNA splicing nonsense-mediated RNA decay RNA-induced gene silencing complex RNA-induced transcriptional silencing 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Ambros, V., Lee, R.C., Lavanway, A., Williams, P.T., Jewell, D. (2003). MicroRNAs and other tiny endogenous RNAs in C. elegans. Curr Biol. 13, 807–818.PubMedCrossRefGoogle Scholar
  2. 2.
    Lin, S.L., Chang, D., Wu, D.Y., Ying, S.Y. (2003). A novel RNA splicing-mediated gene silencing mechanism potential for genome evolution. Biochem Biophys Res Commun. 310, 754–760.PubMedCrossRefGoogle Scholar
  3. 3.
    Rodriguez, A., Griffiths-Jones, S., Ashurst, J.L., Bradley, A. (2004). Identification of mammalian microRNA host genes and transcription units. Genome Res. 14, 1902–1910.PubMedCrossRefGoogle Scholar
  4. 4.
    Lin, S.L., Chuong, C.M., Ying, S.Y. (2001). A Novel mRNA-cDNA interference phenomenon for silencing bcl-2 expression in human LNCaP cells. Biochem. Biophys. Res. Commun. 281, 639–644.PubMedCrossRefGoogle Scholar
  5. 5.
    Ying, S.Y. Lin, S.L. (2004). Intron-derived microRNAs–fine tuning of gene functions. Gene 342, 25–28.PubMedCrossRefGoogle Scholar
  6. 6.
    Clement, J.Q., Qian, L., Kaplinsky, N., Wilkinson, M.F. (1999). The stability and fate of a spliced intron from vertebrate cells. RNA 5, 206–220.PubMedCrossRefGoogle Scholar
  7. 7.
    Parrish, S., Fleenor, J., Xu, S., Mello, C., Fire, A. (2000). Functional anatomy of a dsRNA trigger: Differential requirement for the two trigger strands in RNA interference. Mol. Cell 6, 1077–1087.PubMedCrossRefGoogle Scholar
  8. 8.
    Holen, T., Amarzguioui, M., Wiiger, M.T., Babaie, E., Prydz, H. (2002). Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. Nucleic Acids Res. 30, 1757–1766.PubMedCrossRefGoogle Scholar
  9. 9.
    Hutvagner, G., Zamore, P.D. (2002). A microRNA in a multiple-turnover RNAi enzyme complex. Science 297, 2056–2060.PubMedCrossRefGoogle Scholar
  10. 10.
    Zeng, Y., Yi, R., Cullen, B.R. (2003). MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc. Natl. Acad. Sci. USA 100, 9779–9784.PubMedCrossRefGoogle Scholar
  11. 11.
    Hall, I.M., Shankaranarayana, G.D., Noma, K., Ayoub, N., Cohen, A., Grewal, S.I. (2002). Establishment and maintenance of a heterochromatin domain. Science 297, 2232–2237.PubMedCrossRefGoogle Scholar
  12. 12.
    Llave, C., Xie, Z., Kasschau, K.D., Carrington, J.C. (2002). Cleavage of Scarecrow-like mRNA targets directed by a class of Arabidopsis miRNA. Science 297, 2053–2056.PubMedCrossRefGoogle Scholar
  13. 13.
    Rhoades, M.W., Reinhart, B.J., Lim, L.P., Burge, C.B., Bartel, B., Bartel, D.P. (2002). Prediction of plant microRNA targets. Cell 110, 513–520.PubMedCrossRefGoogle Scholar
  14. 14.
    Lee, R.C., Feibaum, R.L., Ambros, V. (1993). The C. elegans heterochromic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843–854.PubMedCrossRefGoogle Scholar
  15. 15.
    Reinhart, B.J., Slack, F.J., Basson, M., Pasquinelli, A.E., Bettinger, J.C., Rougvie, A.E., Horvitz, H.R., Ruvkun, G. (2000). The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901–906.PubMedCrossRefGoogle Scholar
  16. 16.
    Lau, N.C., Lim, L.P., Weinstein, E.G., Bartel, D.P. (2001). An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294, 858–862.PubMedCrossRefGoogle Scholar
  17. 17.
    Brennecke, J., Hipfner, D.R., Stark, A., Russell, R.B., Cohen, S.M. (2003). Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113, 25–36.PubMedCrossRefGoogle Scholar
  18. 18.
    Xu, P., Vernooy, S.Y., Guo, M., Hay, B.A. (2003). The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr Biol. 13, 790–795.PubMedCrossRefGoogle Scholar
  19. 19.
    Lagos-Quintana, M., Rauhut, R., Meyer, J., Borkhardt, A., Tuschl, T. (2003). New microRNAs from mouse and human. RNA 9, 175–179.PubMedCrossRefGoogle Scholar
  20. 20.
    Mourelatos, Z., Dostie, J., Paushkin, S., Sharma, A., Charroux, B., Abel, L., Rappsilber, J., Mann, M., Dreyfuss, G. (2002). miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 16, 720–728.PubMedCrossRefGoogle Scholar
  21. 21.
    Zeng, Y., Wagner, E.J., Cullen, B.R. (2002). Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol Cell 9, 1327–1333.PubMedCrossRefGoogle Scholar
  22. 22.
    Lin, S.L., Chuong, C.M., Ying, S.Y. (2001). D-RNAi (messenger RNA-antisense DNA interference) as a novel defense system against cancer and viral infections. Curr. Cancer Drug Targets 1, 241–247.PubMedCrossRefGoogle Scholar
  23. 23.
    Lin, S.L. Ying, S.Y. (2005). D-RNAi-Based Therapeutics. In Los, M. Gibson, S. (Eds.), Apoptotic Pathways as Targets for Novel Therapies in Cancer & Other Diseases. Kluwer press, New York, pp. 275–296.CrossRefGoogle Scholar
  24. 24.
    O’Donnell, K.A. Boeke, J.D. (2007). Mighty Piwis defend the germline against genome intruders. Cell 129, 37–44.PubMedCrossRefGoogle Scholar
  25. 25.
    Handa, V., Saha, T., Usdin, K. (2003). The fragile X syndrome repeats form RNA hairpins that do not activate the interferon-inducible protein kinase, PKR, but are cut by Dicer. Nucleic Acids Res. 31, 6243–6248.PubMedCrossRefGoogle Scholar
  26. 26.
    Krol, J., Fiszer, A., Mykowska, A., Sobczak, K., de Mezer, M., Krzyzosiak, W.J. (2007). Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets. Mol Cell 25, 575–586.PubMedCrossRefGoogle Scholar
  27. 27.
    Lin, S.L., Chang, D.C., Ying, S.Y. (2005). Asymmetry of intronic pre-microRNA structures in functional RISC assembly. Gene 356, 32–38.PubMedCrossRefGoogle Scholar
  28. 28.
    Yi, R., Qin, Y., Macara, I.G., Cullen, B.R. (2003). Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17, 3011–3016.PubMedCrossRefGoogle Scholar
  29. 29.
    Lund, E., Guttinger, S., Calado, A., Dahlberg, J.E., Kutay, U. (2004). Nuclear export of microRNA precursors. Science 303, 95–98.PubMedCrossRefGoogle Scholar
  30. 30.
    Lin, S.L., Chang, S.J.E., Ying, S.Y. (2006) First in vivo evidence of microRNA-induced fragile X mental retardation syndrome. Mol Psychiatry 11, 616–617.PubMedCrossRefGoogle Scholar
  31. 31.
    Lee, Y.S., Nakahara, K., Pham, J.W., Kim, K., He, Z., Sontheimer, E.J., Carthew, R.W. (2004). Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell 117, 69–81.PubMedCrossRefGoogle Scholar
  32. 32.
    Tang, G. (2005). siRNA and miRNA: an insight into RISCs. Trends Biochem. Sci. 30, 106–114.PubMedCrossRefGoogle Scholar
  33. 33.
    Liquori, C.L., Ricker, K., Moseley, M.L., Jacobsen, J.F., Kress, W., Naylor, S.L., Day, J.W., Ranum, L.P.W. (2001). Myotinic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293, 864–867.PubMedCrossRefGoogle Scholar
  34. 34.
    Fu, Y.H., Kuhl, D.P.A., Pizzuti, A., Pieretti, M., Sutcliffe, J.S., Richards, S., et al. (1991). Variation of the CGG repeat X site results in genetic instability. Resolution of Sherman paradox. Cell 67, 1047–1058.PubMedCrossRefGoogle Scholar
  35. 35.
    Hagerman, R.J., Staley, L.W., O’Conner, R., Lugenbeel, K., Nelson, D., McLean, S.D., Taylor, A. (1996). Learning-disabled males with a fragile X CGG expansion in the upper premutation size range. Pediatrics 97, 122–126.PubMedGoogle Scholar
  36. 36.
    Jin, P., Zarnescu, D.C., Zhang, F., Pearson, C.E., Lucchesi, J.C., Moses, K., Warren, S.T. (2003). RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron 39, 739–747.PubMedCrossRefGoogle Scholar
  37. 37.
    Genc, B., Muller-Hartmann, H., Zeschnigk, M., Deissler, H., Schmitz, B., Majewski, F., von Gontard, A., Doerfler, W. (2000). Methylation mosaicism of 5′-(CGG)(n)-3′ repeats in fragile X, premutation and normal individuals. Nucleic Acids Res. 28, 2141–2152.PubMedCrossRefGoogle Scholar
  38. 38.
    Jin, P., Alisch, R.S., Warren, S.T. (2004). RNA and microRNAs in fragile X mental retardation. Nat Cell Biol. 6, 1048–1053.PubMedCrossRefGoogle Scholar
  39. 39.
    Miyagishi, M. Taira, K. (2002). U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol. 20, 497–500.PubMedCrossRefGoogle Scholar
  40. 40.
    Lee, N.S., Dohjima, T., Bauer, G., Li, H., Li, M.J., Ehsani, A., Salvaterra, P., Rossi, J. (2002). Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol. 20, 500–505.PubMedGoogle Scholar
  41. 41.
    Paul, C.P., Good, P.D., Winer, I., Engelke, D.R. (2002). Effective expression of small interfering RNA in human cells. Nat Biotechnol. 20, 505–508.PubMedCrossRefGoogle Scholar
  42. 42.
    Xia, H., Mao, Q., Paulson, H.L., Davidson, B.L. (2002). siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol. 20, 1006–1010.PubMedCrossRefGoogle Scholar
  43. 43.
    McCaffrey, A.P., Meuse, L., Pham, T.T., Conklin, D.S., Hannon, G.J., Kay, M.A. (2002). RNA interference in adult mice. Nature 418, 38–39.PubMedCrossRefGoogle Scholar
  44. 44.
    Gunnery, S., Ma, Y., Mathews, M.B. (1999). Termination sequence requirements vary among genes transcribed by RNA polymerase III. J Mol Biol. 286, 745–757.PubMedCrossRefGoogle Scholar
  45. 45.
    Schramm, L. Hernandez, N. (2002). Recruitment of RNA polymerase III to its target promoters. Genes Dev. 16, 2593–2620.CrossRefGoogle Scholar
  46. 46.
    Sledz, C.A., Holko, M., de Veer, M.J., Silverman, R.H., Williams, B.R. 2003) Activation of the interferon system by short-interfering RNAs. Nat Cell Biol. 5, 834–839.PubMedCrossRefGoogle Scholar
  47. 47.
    Lin, S.L. Ying, S.Y. (2004). Combinational therapy for HIV-1 eradication and vaccination. Int. J. Oncol. 24, 81–88.PubMedGoogle Scholar
  48. 48.
    Stark, G.R., Kerr, I.M., Williams, B.R., Silverman, R.H., Schreiber, R.D. (1998). How cells respond to interferons. Annu. Rev. Biochem. 67, 227–264.PubMedCrossRefGoogle Scholar
  49. 49.
    Grimm, D., Streetz, K.L., Jopling, C.L., Storm, T.A., Pandey, K., Davis, C.R., Marion, P., Salazar, F., Kay, M.A. (2006). Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441, 537–541.PubMedCrossRefGoogle Scholar
  50. 50.
    Lin, S.L. Ying, S.Y. (2004). New drug design for gene therapy–Taking advantage of introns. Lett Drug Des. Discov. 1, 256–262.CrossRefGoogle Scholar
  51. 51.
    Lin, S.L. Ying, S.Y. (2004) Novel RNAi therapy–Intron-derived microRNA drugs. Drug Des. Rev. 1, 247–255.Google Scholar
  52. 52.
    Zhou, H.S.L., Xia, X.G., Xu, Z. (2005). An RNA polymerase II construct synthesizes short hairpin RNA with a quantitative indicator and mediates high efficient RNAi. Nucleic Acid Res. 33, e62.PubMedCrossRefGoogle Scholar
  53. 53.
    Chung, K.H., Hart, C.C., Al-Bassam, A., Avery, S., Taylor, J., Patel, P.D., Vojtek, A.B., Turner, D.L. (2006). Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. Nucleic Acid Res. 34, e53.PubMedCrossRefGoogle Scholar
  54. 54.
    Xia, X.G., Zhou, H., Samper, E., Melov, S., Xu, Z. (2006). Pol II-expressed shRNA knocks down Sod2 gene expression and causes phenotypes of the gene knockout in mice. PLoS Genet. 2, e10.PubMedCrossRefGoogle Scholar
  55. 55.
    Nott, A., Meislin, S.H., Moore, M.J. (2003). A quantitative analysis of intron effects on mammalian gene expression. RNA 9, 607–617.PubMedCrossRefGoogle Scholar
  56. 56.
    Zhang, G., Taneja, K.L., Singer, R.H., Green, M.R. (1994). Localization of pre-mRNA splicing in mammalian nuclei. Nature 372, 809–812.PubMedGoogle Scholar
  57. 57.
    Ghosh, S. Garcia-Blanco, M.A. (2000). Coupled in vitro synthesis and splicing of RNA polymerase II transcripts. RNA 6, 1325–1334.PubMedCrossRefGoogle Scholar
  58. 58.
    Bateman, J.R. Wu, C.T. (2007). DNA replication and models for the origin of piRNAs. Bioessays 29, 382–385.PubMedCrossRefGoogle Scholar
  59. 59.
    Lin, S.L., Chang, D.C., Ying, S.Y. (2007). Hyaluronan stimulates transformation of androgen-independent prostate cancer. Carcinogenesis 28, 310–320.PubMedCrossRefGoogle Scholar
  60. 60.
    Lin, S.L., Ying, S.Y. (2006). Gene silencing in vitro and in vivo using intronic microRNAs. Methods Mol Biol. 342, 295–312.PubMedGoogle Scholar
  61. 61.
    Lin, S.L., Chang, S.J.E., Ying, S.Y. (2006). Transgene-like animal model using intronic microRNAs. Methods Mol Biol. 342, 321–334.PubMedGoogle Scholar
  62. 62.
    Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Radmark, O., Kim, S., Kim, V.N. (2003). The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415–419.PubMedCrossRefGoogle Scholar
  63. 63.
    Butz, S. Larue, L. (1995). Expression of catenins during mouse embryonic development and in adult tissues. Cell Adhes Commun. 3, 337–352.PubMedCrossRefGoogle Scholar
  64. 64.
    Filipovska, J. Konarska, M.M. (2000). Specific HDV RNA-templated transcription by pol II in vitro. RNA 6, 41–54.PubMedCrossRefGoogle Scholar
  65. 65.
    Modahl, L.E., Macnaughton, T.B., Zhu, N., Johnson, D.L., Lai, M.M. (2000). RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases. Mol Cell Biol. 20, 6030–6039.PubMedCrossRefGoogle Scholar
  66. 66.
    Vagin, V.V., Sigova, A., Li, C., Seitz, H., Gvozdev, V., Zamore, P.D. (2006). A distinct small RNA pathway silences selfish genetic elements in the germline. Science 313, 320–324.PubMedCrossRefGoogle Scholar
  67. 67.
    Carmell, M.A., Girard, A., van de Kant, H.J., Bourc’his, D., Bestor, T.H., de Rooij, D.C., and Hamnon, G.J. (2007). MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male germline. Dev. Cell 12, 503–514.Google Scholar
  68. 68.
    Abzhanov, A., Protas, M., Grant, B.R., Grant, P.R., Tabin, C.J. (2004). Bmp4 and morphological variation of beaks in Darwin’s finches. Science 305, 1462–1465.PubMedCrossRefGoogle Scholar
  69. 69.
    Wu, P., Jiang, T.X., Suksaweang, S., Widelitz, R.B., Chuong, C.M. (2004). Molecular shaping of the beak. Science 305, 1465–1466.PubMedCrossRefGoogle Scholar
  70. 70.
    Sheth, U. Parker, R. (2006). Targeting of aberrant mRNAs to cytoplasmic processing bodies. Cell 125, 1095–1109.PubMedCrossRefGoogle Scholar
  71. 71.
    Kovacs, J.A., Vogel, S., Albert, J.M., Falloon, J., Davey, R.T. Jr., Walker, R.E., Polis, M.A., Spooner, K., Metcalf, J.A., Baseler, M., Fyfe, G., Lane, H.C. (1996). Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N Engl. J. Med. 335, 1350–1356.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Department of Cell & Neurobiology, Keck School of MedicineUniversity of Southern CaliforniaLos Angeles,CAUSA

Personalised recommendations

Cite protocol

Buy options